Romaric Loffroy1, Béatrice Terriat1, Valérie Jooste1, Isabelle Robin1, Marie-Claude Brindisi1, Patrick Hillon1, Bruno Vergès1, Jean-Pierre Cercueil1, Jean-Michel Petit1. 1. 1 Department of Vascular and Interventional Radiology, François-Mitterrand Teaching Hospital, University of Burgundy, Dijon, France ; 2 LE2I, UMR CNRS 6306, University of Burgundy, Dijon, France ; 3 Department of Angiology, François-Mitterrand Teaching Hospital, University of Burgundy, Dijon, France ; 4 Inserm U866, University of Burgundy, Dijon, France ; 5 Department of Endocrinology, Diabetes and Nutrition, 6 Department of Hepatology, François-Mitterrand Teaching Hospital, University of Burgundy, Dijon, France.
Abstract
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is independently associated with atherosclerosis in nondiabetic individuals. In type 2 diabetic patients, the link between fatty liver and atherosclerosis is less clear. Here, we assessed whether liver fat content evaluated using (1)H-magnetic resonance spectroscopy ((1)H-MRS) was independently associated with prevalent carotid plaque as a marker of atherosclerosis in type 2 diabetic patients. METHODS: One hundred and forty-four prospectively enrolled patients with type 2 diabetes underwent liver fat content measurement using (1)H-MRS and carotid plaque assessment using ultrasound. Multiple logistic regressions were used to identify factors associated with carotid plaque. RESULTS: Mean ± SD liver fat content was 9.86±8.12%. Carotid plaque prevalence was 52.1% (75/144). Patients without plaque were younger (P=0.006) and had a smaller visceral fat area (P=0.015), lower reported prevalence of previous cardiovascular events or current statin therapy (P=0.002), and higher liver fat content than those with plaque (P=0.009). By multivariable logistic regression, increased liver fat content independently predicted the absence of carotid plaque [odds ratios (ORs), 0.94; 95% confidence intervals (CIs), 0.89-0.99; P=0.017]. CONCLUSIONS: Liver fat content measured by (1)H-MRS is higher in type 2 diabetic patients without carotid plaque compared to those with plaque. This study suggests that increased liver fat content could be associated with a relative protection against carotid atherosclerosis in patients with type 2 diabetes mellitus.
BACKGROUND:Nonalcoholic fatty liver disease (NAFLD) is independently associated with atherosclerosis in nondiabetic individuals. In type 2 diabeticpatients, the link between fatty liver and atherosclerosis is less clear. Here, we assessed whether liver fat content evaluated using (1)H-magnetic resonance spectroscopy ((1)H-MRS) was independently associated with prevalent carotid plaque as a marker of atherosclerosis in type 2 diabeticpatients. METHODS: One hundred and forty-four prospectively enrolled patients with type 2 diabetes underwent liver fat content measurement using (1)H-MRS and carotid plaque assessment using ultrasound. Multiple logistic regressions were used to identify factors associated with carotid plaque. RESULTS: Mean ± SD liver fat content was 9.86±8.12%. Carotid plaque prevalence was 52.1% (75/144). Patients without plaque were younger (P=0.006) and had a smaller visceral fat area (P=0.015), lower reported prevalence of previous cardiovascular events or current statin therapy (P=0.002), and higher liver fat content than those with plaque (P=0.009). By multivariable logistic regression, increased liver fat content independently predicted the absence of carotid plaque [odds ratios (ORs), 0.94; 95% confidence intervals (CIs), 0.89-0.99; P=0.017]. CONCLUSIONS: Liver fat content measured by (1)H-MRS is higher in type 2 diabeticpatients without carotid plaque compared to those with plaque. This study suggests that increased liver fat content could be associated with a relative protection against carotid atherosclerosis in patients with type 2 diabetes mellitus.
Authors: Zobair M Younossi; Terry Gramlich; Christi A Matteoni; Navdeep Boparai; Arthur J McCullough Journal: Clin Gastroenterol Hepatol Date: 2004-03 Impact factor: 11.382
Authors: G Targher; L Bertolini; R Padovani; F Poli; L Scala; L Zenari; G Zoppini; G Falezza Journal: J Endocrinol Invest Date: 2006-01 Impact factor: 4.256
Authors: Fida Bacha; Anca Tomsa; Sara K Bartz; Sarah E Barlow; Zili David Chu; Ramkumar Krishnamurthy; Rajesh Krishnamurthy; E O'Brian Smith Journal: J Endocr Soc Date: 2017-06-27
Authors: Anders Gummesson; Ulf Strömberg; Caroline Schmidt; Joel Kullberg; Oskar Angerås; Stefan Lindgren; Ola Hjelmgren; Kjell Torén; Annika Rosengren; Björn Fagerberg; John Brandberg; Göran Bergström Journal: PLoS One Date: 2018-08-22 Impact factor: 3.240